peripheral insulin intra cellular receptor.[hide]v • d • eOral antidiabetic drugs and Insulin analogs (A10)Biguanides MetforminSulfonylureas Chlorpropamide, Glibenclamide (Glyburide), Gliclazide, Glimepiride, Glipizide, Gliquidone, drug amaryl TolbutamideAlpha-glucosidase inhibitors Acarbose, Miglitol.

93479-97-1ATC code A10BB12PubChem 3476DrugBank APRD00381Chemical dataFormula C24H34N4O5SMol. mass 490.617 g/molPharmacokinetic dataBioavailability ?Protein binding >99.5%Metabolism ?Half life ?Excretion ?Therapeutic considerationsPregnancy cat. ?Legal statusRoutes ?Glimepiride is a medium-to-long acting sulfonylurea anti-diabetic drug. It is marketed as Amaryl by Sanofi-Aventis. Glimepiride is the first third-generation sulfonylurea, and is very potent.Contents [hide]1 Indications2 drug amaryl effects3 Contraindications4 Interactions5 Pharmacology6 drug amaryl of action[edit] drug amaryl 2 diabetes (NIDDM).[edit] Adverse effectsMain article: SulfonylureaGI disturbance, rarely thrombopenia , leucopenia, haemolytic anaemia, occasionally allergic. In the initial weeks of treatment, the risk of hypoglycemia may be increased.[edit] drug amaryl to glimepiride or other sulfonylureas. -Pregnancy[edit] InteractionsWith drug amaryl like Salicylates, drug amaryl Chlorampenicol.

peptide-1 analog ExenatideAmylin analog PramlintideInsulin analogs fast acting (Insulin lispro, Insulin.